197 related articles for article (PubMed ID: 28825922)
1. Risk stratification in oligometastatic prostate cancer: where are we and what do we need?
Morgans AK; Hussain M
Curr Opin Urol; 2017 Nov; 27(6):547-552. PubMed ID: 28825922
[TBL] [Abstract][Full Text] [Related]
2. Oligometastatic prostate cancer: shaping the definition with molecular imaging and an improved understanding of tumor biology.
Joice GA; Rowe SP; Pienta KJ; Gorin MA
Curr Opin Urol; 2017 Nov; 27(6):533-541. PubMed ID: 28863016
[TBL] [Abstract][Full Text] [Related]
3. Oligometastatic prostate cancer: Reality or figment of imagination?
Foster CC; Weichselbaum RR; Pitroda SP
Cancer; 2019 Feb; 125(3):340-352. PubMed ID: 30521067
[TBL] [Abstract][Full Text] [Related]
4. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
[TBL] [Abstract][Full Text] [Related]
5. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
[TBL] [Abstract][Full Text] [Related]
6. Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer.
Clement JM; Sweeney CJ
J Oncol Pract; 2017 Jan; 13(1):9-18. PubMed ID: 28045610
[TBL] [Abstract][Full Text] [Related]
7. [Surgical treatment of local disease in metastatic prostate cancer.].
Gaya JM; Huguet J; Breda A; Palou J
Arch Esp Urol; 2018 Mar; 71(3):288-297. PubMed ID: 29633950
[TBL] [Abstract][Full Text] [Related]
8. [Oligometastatic prostate cancer. concept and implications.].
Carrasco Valiente J; Ruiz García JM; Requena Tapia MJ
Arch Esp Urol; 2018 Mar; 71(3):239-246. PubMed ID: 29633944
[TBL] [Abstract][Full Text] [Related]
9. Oligometastasis: Past, Present, Future.
Gutiontov SI; Pitroda SP; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):530-538. PubMed ID: 32976785
[TBL] [Abstract][Full Text] [Related]
10. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
Kim J; Park JS; Ham WS
Investig Clin Urol; 2017 Sep; 58(5):307-316. PubMed ID: 28868501
[TBL] [Abstract][Full Text] [Related]
11. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
12. Oligometastatic Prostate Cancer: Current Status and Future Challenges.
Jadvar H; Abreu AL; Ballas LK; Quinn DI
J Nucl Med; 2022 Nov; 63(11):1628-1635. PubMed ID: 36319116
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy for local disease in metastatic prostate cancer.].
Cambeiro M; Calvo FA
Arch Esp Urol; 2018 Mar; 71(3):298-305. PubMed ID: 29633951
[TBL] [Abstract][Full Text] [Related]
14. What Is Oligometastatic Prostate Cancer?
Fraser M; Koontz B; Emmenegger U; De Meerleer G; Khoo V; Feng F; Corcoran NM; Hovens CM; Tran PT; Ost P; Boutros PC;
Eur Urol Focus; 2019 Mar; 5(2):159-161. PubMed ID: 30642810
[TBL] [Abstract][Full Text] [Related]
15. Approach to Oligometastatic Prostate Cancer.
Bernard B; Gershman B; Karnes RJ; Sweeney CJ; Vapiwala N
Am Soc Clin Oncol Educ Book; 2016; 35():119-29. PubMed ID: 27249693
[TBL] [Abstract][Full Text] [Related]
16. [Oligometastatic prostate cancer management].
Kleinclauss F; Thiery-Vuillemin A
Prog Urol; 2019 Jun; 29 Suppl 1():S20-S34. PubMed ID: 31307628
[TBL] [Abstract][Full Text] [Related]
17. Developments in oligometastatic hormone-sensitive prostate cancer.
Chow K; McCoy P; Stuchbery R; Corcoran NM; Hovens CM
World J Urol; 2019 Dec; 37(12):2549-2555. PubMed ID: 30382379
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review.
Koo KC; Dasgupta P
Yonsei Med J; 2018 Jul; 59(5):567-579. PubMed ID: 29869454
[TBL] [Abstract][Full Text] [Related]
19. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.
Gandaglia G; Fossati N; Stabile A; Bandini M; Rigatti P; Montorsi F; Briganti A
Eur Urol; 2017 Aug; 72(2):289-292. PubMed ID: 27574820
[TBL] [Abstract][Full Text] [Related]
20. Oligometastatic Prostate Cancer: Is it Only a Matter of Perspective?
Di Lorenzo G; Buonerba C
Eur Urol; 2019 May; 75(5):705-706. PubMed ID: 30591352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
